4.4 Article

Paracrine relationship between incretin hormones and endogenous 5-hydroxytryptamine in the small and large intestine

期刊

NEUROGASTROENTEROLOGY AND MOTILITY
卷 35, 期 8, 页码 -

出版社

WILEY
DOI: 10.1111/nmo.14589

关键词

5-hydroxytryptamine; enterochromaffin cells; gastric inhibitory polypeptide; glucagon-like peptide-1; motility; mucosal ion transport

向作者/读者索取更多资源

This study investigates the efficacy of 5-HT signaling and its interaction with incretin hormones in different regions of the mouse intestine. The results show that 5-HT has the highest levels in the ascending colon mucosa and acts through both 5-HT3 and 5-HT4 receptors. Additionally, GLP-1 and GIP have interactions with 5-HT and affect the colonic mucosa.
BackgroundEnterochromaffin (EC) cell-derived 5-hydroxytryptamine (5-HT) is a mediator of toxin-induced reflexes, initiating emesis via vagal and central 5-HT3 receptors. The amine is also involved in gastrointestinal (GI) reflexes that are prosecretory and promotile, and recently 5-HT's roles in chemosensation in the distal bowel have been described. We set out to establish the efficacy of 5-HT signaling, local 5-HT levels and pharmacology in discrete regions of the mouse small and large intestine. We also investigated the inter-relationships between incretin hormones, glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP) and endogenous 5-HT in mucosal and motility assays. MethodsAdult mouse GI mucosae were mounted in Ussing chambers and area-specific studies were performed to establish the 5-HT3 and 5-HT4 pharmacology, the sidedness of responses, and the inter-relationships between incretins and endogenous 5-HT. Natural fecal pellet transit in vitro and full-length GI transit in vivo were also measured. Key ResultsWe observed the greatest level of tonic and exogenous 5-HT-induced ion transport and highest levels of 5-HT in ascending colon mucosa. Here both 5-HT3 and 5-HT4 receptors were involved but elsewhere in the GI tract epithelial basolateral 5-HT4 receptors mediate 5-HT's prosecretory effect. Exendin-4 and GIP induced 5-HT release in the ascending colon, while L cell-derived PYY also contributed to GIP mucosal effects in the descending colon. Both peptides slowed colonic transit. Conclusions & InferencesWe provide functional evidence for paracrine interplay between 5-HT, GLP-1 and GIP, particularly in the colonic mucosal region. Basolateral epithelial 5-HT4 receptors mediated both 5-HT and incretin mucosal responses in healthy colon.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Allergy

Activation of succinate receptor 1 boosts human mast cell reactivity and allergic bronchoconstriction

Xiao Tang, Elin Ronnberg, Jesper Safholm, Madhuranayaki Thulasingam, Mette Trauelsen, Thue W. Schwartz, Craig E. Wheelock, Sven-Erik Dahlen, Gunnar Nilsson, Jesper Z. Haeggstrom

Summary: SUCNR1 amplifies IgE-receptor-induced mast cell activation and allergic bronchoconstriction, suggesting a role for this pathway in aggravation of allergic asthma. Pharmacologically targeting protein kinase C and extracellular signal-regulated kinase can modulate succinate-potentiated mast cell reactivity.

ALLERGY (2022)

Article Chemistry, Medicinal

Optimization of First-in-Class Dual-Acting FFAR1/FFAR4 Allosteric Modulators with Novel Mode of Action

Michael Luckmann, Aslihan Shenol, Tinne A. D. Nissen, Jacob E. Petersen, David Kouvchinov, Thue W. Schwartz, Thomas M. Frimurer

Summary: The free fatty acid receptors FFAR1 and FFAR4 hold potential as therapeutic targets for metabolic and inflammatory diseases. However, the pharmaceutical industry has abandoned many lipophilic compounds due to toxic effects. A recent discovery by our group involves a compound that acts as an allosteric agonist on FFAR1. In this study, we present the synthesis and structure-activity relationship investigation of analogues displaying dual-acting agonist properties for both FFAR1 and FFAR4. Multiple analogues with high potency on FFAR1 have been discovered, offering new ways to achieve beneficial glycemic control without toxic side effects.

ACS MEDICINAL CHEMISTRY LETTERS (2022)

Article Multidisciplinary Sciences

Type 2 diabetes is associated with increased circulating levels of 3-hydroxydecanoate activating GPR84 and neutrophil migration

Randi Bonke Mikkelsen, Tulika Arora, Kajetan Trost, Oksana Dmytriyeva, Sune Kjaersgaard Jensen, Abraham Stijn Meijnikman, Louise Elisabeth Olofsson, Dimitra Lappa, Omrum Aydin, Jens Nielsen, Victor Gerdes, Thomas Moritz, Arnold van de Laar, Maurits de Brauw, Max Nieuwdorp, Siv Annegrethe Hjorth, Thue Walter Schwartz, Fredrik Backhed

Summary: This study found that 3-hydroxydecanoate is enriched in the circulation of obese individuals with type 2 diabetes and is associated with chronic inflammation. Administration of 3-hydroxydecanoate to mice promotes immune cell recruitment to adipose tissue, leading to adipose inflammation and increased insulin levels. Furthermore, 3-hydroxydecanoate stimulates migration of human and mouse neutrophils through GPR84 and Gai signaling.

ISCIENCE (2022)

Article Endocrinology & Metabolism

Cell selectivity in succinate receptor SUCNR1/GPR91 signaling in skeletal muscle

Ahmed M. Abdelmoez, Oksana Dmytriyeva, Yasemin-Xiomara Zurke, Mette Trauelsen, Alesandra A. Marica, Mladen Savikj, Jonathon A. B. Smith, Claudia Monaco, Thue W. Schwartz, Anna Krook, Nicolas J. Pillon

Summary: Succinate released by skeletal muscle activates SUCNR1/GPR91, but it is unclear which cell types respond to succinate and the directionality of communication. This study found that SUCNR1 is expressed in macrophages but not in muscle cells, suggesting that the adaptive response of skeletal muscle to exercise is mediated via paracrine mechanisms involving macrophages.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2023)

Article Cardiac & Cardiovascular Systems

Pyruvate dehydrogenase kinase regulates vascular inflammation in atherosclerosis and increases cardiovascular risk

Maria J. Forteza, Martin Berg, Andreas Edsfeldt, Jangming Sun, Roland Baumgartner, Ilona Kareinen, Felipe Beccaria Casagrande, Ulf Hedin, Song Zhang, Ivan Vuckovic, Petras P. Dzeja, Konstantinos A. Polyzos, Anton Gistera, Mette Trauelsen, Thue W. Schwartz, Lea Dib, Joerg Herrmann, Claudia Monaco, Ljubica Matic, Isabel Goncalves, Daniel F. J. Ketelhuth

Summary: Recent studies have shown a link between cellular metabolism and the chronic inflammatory process of atherosclerosis. The PDK/PDH axis has been identified as a major metabolic pathway regulating vascular inflammation and atherogenesis, and targeting it with DCA could be a promising treatment for atherosclerosis.

CARDIOVASCULAR RESEARCH (2023)

Article Biochemistry & Molecular Biology

The dietary regulation of LEAP2 depends on meal composition in mice

Anna Katrina Jogvansdottir Gradel, Stephanie K. K. Holm, Sarah Byberg, Myrte Merkestein, Wouter Frederik Johan Hogendorf, Mari Lilith Lund, Jesse Arnold Buijink, Jesper Damgaard, Jens Lykkesfeldt, Birgitte Holst

Summary: Ghrelin is a key hormone regulating energy balance, while LEAP2 acts as an endogenous antagonist of the GHSR. This study found that different meal challenges and diets can regulate the expression and secretion of LEAP2 in the small intestine and liver.

FASEB JOURNAL (2023)

Article Chemistry, Medicinal

Structure-Activity Relationship Study of the High-Affinity Neuropeptide Y4 Receptor Positive Allosteric Modulator VU0506013

Corinna Schuess, Oanh Vu, Nigam M. Mishra, Iain R. Tough, Yu Du, Jan Stichel, Helen M. Cox, C. David Weaver, Jens Meiler, Kyle A. Emmitte, Annette G. Beck-Sickinger

Summary: In this study, a novel positive allosteric modulator (PAM) VU0506013 targeting the Y4R receptor was identified. It showed nanomolar affinity and selectivity towards the Y4R and has potential for anti-obesity research.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Multidisciplinary Sciences

Self-organized metabotyping of obese individuals identifies clusters responding differently to bariatric surgery

Dimitra M. Lappa, Abraham S. Meijnikman, Kimberly A. Krautkramer, Lisa M. Olsson, Omrum Aydin, Anne-Sophie Van Rijswijk, Yair I. Z. E. Acherman, Maurits De Brauw, Valentina A. Tremaroli, Louise E. Olofsson, Annika Lundqvist, Siv A. K. Hjorth, Boyang W. Ji, Victor E. A. Gerdes, Albert K. Groen, Thue W. Schwartz, Max Nieuwdorp, Fredrik Baeckhed, Jens Nielsen

Summary: Weight loss through bariatric surgery is effective in treating or preventing obesity related diseases, but the long-term weight loss response varies among patients. This study conducted multiple omics analyses on individuals undergoing bariatric surgery to identify metabolic differences and explore their relationship with weight loss response. Five distinct metabotypes were identified based on plasma metabolome analysis, showing differential enrichment in pathways related to immune functions, fatty acid metabolism, protein signaling, and obesity pathogenesis. The gut metagenome of the heavily medicated metabotypes was significantly enriched in Prevotella and Lactobacillus species. Each metabotype responded differently to bariatric surgery in terms of weight loss after 12 months. This study provides a path for patient stratification and improved clinical treatments.

PLOS ONE (2023)

Article Nutrition & Dietetics

In Vitro Screening for Probiotic Properties of Lactobacillus and Bifidobacterium Strains in Assays Relevant for Non-Alcoholic Fatty Liver Disease Prevention

Silvia Lopez-Escalera, Mari L. L. Lund, Gerben D. A. Hermes, Beatrice S. -Y. Choi, Kei Sakamoto, Anja Wellejus

Summary: Non-alcoholic fatty liver disease (NAFLD) is a metabolic disorder that is associated with various health issues and is expected to increase in prevalence. Disturbance of tight junction proteins can lead to increased gut permeability and the passage of harmful microbial components to the liver, triggering inflammation and cellular stress. Targeted probiotic supplements have been proposed as a preventive therapy to improve gut barrier function and promote beneficial effects on liver health.

NUTRIENTS (2023)

Article Endocrinology & Metabolism

Free fatty acid receptor 1 stimulates cAMP production and gut hormone secretion through Gq-mediated activation of adenylate cyclase 2

Jacob Emil Petersen, Maria Hauge Pedersen, Oksana Dmytriyeva, Emilie Nellemose, Tulika Arora, Maja Storm Engelstoft, Wesley B. Asher, Jonathan A. Javitch, Thue W. Schwartz, Mette Trauelsen

Summary: The activation of FFAR1 can induce both IP3/Ca2+ signaling pathway and cAMP signaling pathway, and the co-activation of these two pathways is required for the highly efficient hormone secretion induced by second-generation FFAR1 agonists. Adcy2 gene is highly expressed in enteroendocrine cells of the intestine and may mediate Gq-driven cAMP signaling response.

MOLECULAR METABOLISM (2023)

Article Pharmacology & Pharmacy

Serotonin receptor 4 agonism prevents high fat diet induced reduction in GLP-1 in mice

Amanda Marie Vanslette, Pernille Baumann Toft, Mari Lilith Lund, Thomas Moritz, Tulika Arora

Summary: This study found that a high fat diet can reduce the expression and secretion of gut hormones, as well as decrease GLP-1 levels. Supplementation of sodium propionate did not improve this condition, while chemical induction of serotonin receptor 4 can increase GLP-1 levels and improve glucose tolerance.

EUROPEAN JOURNAL OF PHARMACOLOGY (2023)

Article Oncology

Lactate receptor GPR81 drives breast cancer growth and invasiveness through regulation of ECM properties and Notch ligand DLL4

Kathrine Lundo, Oksana Dmytriyeva, Louise Spohr, Eliana Goncalves-Alves, Jiayi Yao, Laia P. Blasco, Mette Trauelsen, Muthulakshmi Ponniah, Marc Severin, Albin Sandelin, Marie Kveiborg, Thue W. Schwartz, Stine F. Pedersen

Summary: This study reveals the mechanism of lactate receptor GPR81 in breast cancer, which promotes tumor invasiveness by downregulating the Notch pathway ligand DLL4. This finding is of great significance for the treatment of breast cancer.

BMC CANCER (2023)

暂无数据